Actinogen Medical Limited
ASX:ACW.AX
0.025 (AUD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.932 | 4.888 | 3.64 | 1.984 | 3.516 | 4.863 | 3.301 | 1.415 | 3.953 | 0.153 | 0.181 | 0.003 | 0.052 | 0.094 | 0.093 | 0.128 | 0.156 |
| Cost of Revenue
| 0.417 | 0.406 | 0.401 | 0.387 | 0.413 | 0.354 | 0.356 | 0.361 | 0.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 9.515 | 4.482 | 3.239 | 1.597 | 3.103 | 4.509 | 2.945 | 1.055 | 3.588 | 0.153 | 0.181 | 0.003 | 0.052 | 0.094 | 0.093 | 0.128 | 0.156 |
| Gross Profit Ratio
| 0.958 | 0.917 | 0.89 | 0.805 | 0.883 | 0.927 | 0.892 | 0.745 | 0.908 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 15.535 | 8.9 | 8.215 | 2.406 | 5.537 | 10.895 | 7.742 | 3.19 | 5.613 | 2.758 | 0.219 | 0.289 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1.732 | 1.794 | 1.36 | 1.117 | 1.229 | 0.659 | 2.269 | 0.685 | 2.157 | 0.601 | 0.194 | 0.183 | 0.715 | 0.699 | 0.632 | 0.677 | 0.423 |
| Selling & Marketing Expenses
| 5.503 | 4.774 | 3.198 | 1.994 | 1.733 | 0.776 | 0.528 | 0.295 | 0.54 | 1.858 | 0.172 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.235 | 6.568 | 4.558 | 3.111 | 2.962 | 3.221 | 1.465 | 1.046 | 1.602 | 2.598 | 0.366 | 0.183 | 0.715 | 0.699 | 0.632 | 0.677 | 0.423 |
| Other Expenses
| 0 | 4.771 | 3.653 | 1.984 | 3.516 | 4.782 | 3.304 | 1.378 | 3.849 | 0 | 0.147 | 0.002 | 0.447 | 0.41 | 0.063 | 0.233 | 0.06 |
| Operating Expenses
| 22.77 | 15.467 | 12.773 | 5.517 | 8.499 | 14.947 | 9.206 | 4.237 | 7.215 | 5.579 | 0.621 | 0.457 | 1.161 | 1.11 | 1.054 | 0.91 | 0.592 |
| Operating Income
| -12.839 | -15.873 | -13.173 | -5.904 | -8.912 | -9.607 | -9.562 | -4.597 | -7.58 | -5.425 | -0.417 | -0.457 | -1.11 | -1.051 | -1.005 | -0.884 | -0.577 |
| Operating Income Ratio
| -1.293 | -3.247 | -3.619 | -2.976 | -2.534 | -1.976 | -2.897 | -3.248 | -1.918 | -35.355 | -2.301 | -147.451 | -21.525 | -11.128 | -10.832 | -6.901 | -3.705 |
| Total Other Income Expenses Net
| -0.205 | 0.233 | 0.036 | 0.149 | 0.266 | -0.28 | 0.174 | 0.147 | 0.198 | -0.006 | -0.023 | -0.003 | -0.689 | -0.009 | 0.044 | -0.297 | 0.142 |
| Income Before Tax
| -13.044 | -15.64 | -13.137 | -5.754 | -8.646 | -9.888 | -9.389 | -4.45 | -7.382 | -5.431 | -0.44 | -0.455 | -1.787 | -1.025 | -0.917 | -1.079 | -0.436 |
| Income Before Tax Ratio
| -1.313 | -3.2 | -3.609 | -2.9 | -2.459 | -2.033 | -2.844 | -3.144 | -1.868 | -35.398 | -2.429 | -146.659 | -34.648 | -10.852 | -9.887 | -8.419 | -2.795 |
| Income Tax Expense
| -9.932 | -4.888 | -3.64 | -1.839 | -3.315 | 0.182 | -3.158 | -1.26 | -3.748 | -0.223 | 0 | -0.29 | -0.257 | -0.283 | -0.18 | -0.152 | 0.142 |
| Net Income
| -13.044 | -10.752 | -9.497 | -3.915 | -5.331 | -9.888 | -6.231 | -3.19 | -3.634 | -5.431 | -0.44 | -0.165 | -1.529 | -0.742 | -0.737 | -0.927 | -0.436 |
| Net Income Ratio
| -1.313 | -2.2 | -2.609 | -1.973 | -1.516 | -2.033 | -1.888 | -2.254 | -0.919 | -35.398 | -2.429 | -53.083 | -29.657 | -7.86 | -7.947 | -7.235 | -2.795 |
| EPS
| -0.006 | -0.006 | -0.005 | -0.003 | -0.005 | -0.009 | -0.008 | -0.005 | -0.006 | -0.012 | -0.003 | -0.004 | -0.042 | -0.033 | -0.031 | -0.039 | -0.02 |
| EPS Diluted
| -0.006 | -0.006 | -0.005 | -0.003 | -0.005 | -0.009 | -0.008 | -0.005 | -0.006 | -0.012 | -0.003 | -0.004 | -0.042 | -0.033 | -0.031 | -0.039 | -0.02 |
| EBITDA
| -12.921 | -15.467 | -12.773 | -5.517 | -8.499 | -9.254 | -9.206 | -4.237 | -7.215 | -5.426 | -0.403 | -0.432 | -1.078 | -0.996 | -0.88 | -0.768 | -0.434 |
| EBITDA Ratio
| -1.301 | -3.164 | -3.509 | -2.781 | -2.417 | -1.903 | -2.789 | -2.993 | -1.825 | -35.365 | -2.226 | -139.36 | -20.899 | -10.544 | -9.484 | -5.993 | -2.785 |